Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures
- PMID: 10352105
- DOI: 10.1359/jbmr.1999.14.6.960
Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures
Abstract
The influence of intermittent parathyroid hormone (PTH(1-34)) administration on callus formation and mechanical strength of tibial fractures in rats was investigated after 20 and 40 days of healing. A dose of 60 microg of PTH(1-34)/kg/day and 200 microg of PTH(1-34)/kg/day, respectively, was administered during the entire periods of healing, and control animals with fractures were given vehicle. The dose of 200 microg of PTH(1-34)/kg/day increased the ultimate load and the external callus volume of the fractures by 75% and 99%, respectively, after 20 days of healing and by 175% and 72%, respectively, after 40 days of healing. The dose of 60 microg of PTH(1-34)/kg/day did not influence either ultimate load or external callus volume of the fractures after 20 days of healing, but the ultimate load was increased by 132% and the external callus volume was increased by 42% after 40 days of healing. During the healing period, the callus bone mineral content (BMC) increased in all groups. After 40 days of healing, the callus BMC was increased by 108% in the 200 microg of PTH(1-34)/kg/day group and by 76% in the 60 microg of PTH(1-34)/kg/day group. Both doses of PTH(1-34) steadily augmented the contralateral intact tibia BMC (20 days and 40 days: 60 microg of PTH (1-34)/kg/day 9% and 19%, respectively; 200 microg of PTH (1-34)/kg/day 12% and 27%, respectively) and bone mineral density (20 days and 40 days: 60 microg of PTH(1-34)/kg/day 11% and 12%, respectively; 200 microg of PTH(1-34)/kg/day 11% and 15%, respectively).
Similar articles
-
Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase.Calcif Tissue Int. 2004 Apr;74(4):351-6. doi: 10.1007/s00223-003-0093-6. Calcif Tissue Int. 2004. PMID: 15255072
-
Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone.Acta Orthop Scand. 2001 Jun;72(3):304-7. doi: 10.1080/00016470152846673. Acta Orthop Scand. 2001. PMID: 11480610
-
Local anabolic effects of growth hormone on intact bone and healing fractures in rats.Calcif Tissue Int. 2003 Sep;73(3):258-64. doi: 10.1007/s00223-002-2074-6. Calcif Tissue Int. 2003. PMID: 14667139
-
[Bone fracture and the healing mechanisms. The effect of human parathyroid hormone on fracture healing].Clin Calcium. 2009 May;19(5):660-6. Clin Calcium. 2009. PMID: 19398833 Review. Japanese.
-
Parathyroid hormone and bone healing.Calcif Tissue Int. 2010 Jul;87(1):1-13. doi: 10.1007/s00223-010-9360-5. Epub 2010 Apr 29. Calcif Tissue Int. 2010. PMID: 20428858 Review.
Cited by
-
Can an anti-fracture agent heal fractures?Clin Cases Miner Bone Metab. 2010 Jan;7(1):11-4. Clin Cases Miner Bone Metab. 2010. PMID: 22461283 Free PMC article.
-
Osteoanabolic Agents for Osteoporosis.J Endocr Soc. 2018 Jul 9;2(8):922-932. doi: 10.1210/js.2018-00118. eCollection 2018 Aug 1. J Endocr Soc. 2018. PMID: 30087947 Free PMC article. Review.
-
Continuous infusion of PTH1-34 delayed fracture healing in mice.Sci Rep. 2018 Sep 4;8(1):13175. doi: 10.1038/s41598-018-31345-1. Sci Rep. 2018. PMID: 30181648 Free PMC article.
-
How to grow bone to treat osteoporosis and mend fractures.Curr Osteoporos Rep. 2003 Jun;1(1):32-40. doi: 10.1007/s11914-003-0006-7. Curr Osteoporos Rep. 2003. PMID: 16036063 Review.
-
Teriparatide (human PTH1-34) compensates for impaired fracture healing in COX-2 deficient mice.Bone. 2018 May;110:150-159. doi: 10.1016/j.bone.2018.02.001. Epub 2018 Feb 3. Bone. 2018. PMID: 29408411 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources